Motusol Max 12-Hour Pain Relief (Diclofenac Sodium)

Diclofenac sodium works by non‑selectively inhibiting the cyclooxygenase enzymes COX‑1 and COX‑2, which are essential for converting arachidonic acid into prostaglandins. By reducing prostaglandin synthesis at the site of application, the gel diminishes inflammation, pain signaling, and vascular changes, delivering targeted relief without substantial systemic exposure.

The appropriate dose and frequency are determined by the prescribing healthcare professional based on the severity of the condition, the size of the treatment area, and patient‑specific factors. Patients should follow the prescriber’s instructions and the product label for the amount to apply and the interval between applications.

Safety data for topical diclofenac in pregnancy and lactation are limited. Healthcare providers generally advise caution and may recommend alternative therapies unless the potential benefit outweighs the risk. Women who are pregnant, planning pregnancy, or breastfeeding should discuss use with their physician before starting treatment.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. The sales team then replies with pricing, availability, shipping details (including any cold‑chain requirements), and the necessary import documentation.

Motusol Max contains diclofenac sodium, a widely studied NSAID with strong COX inhibition. Compared with other topical NSAIDs such as ibuprofen or ketoprofen gels, diclofenac generally offers a longer duration of action (up to twelve hours) and a well‑characterised safety profile. Choice of product should consider the specific indication, patient tolerance, and prescriber preference.

Store the gel at room temperature, preferably below 25 °C. Keep the container tightly closed, in its original packaging, and protect it from moisture, direct sunlight, and extreme heat. Do not freeze the product, as low temperatures may affect its consistency and efficacy.

The gel is applied topically to clean, dry skin over the painful or inflamed area. A thin layer is spread gently and allowed to absorb; the area should not be covered with occlusive dressings unless directed by a healthcare professional. Hands should be washed after application to avoid accidental contact with eyes or mucous membranes.

Serious risks include severe allergic reactions such as angioedema, Stevens‑Johnson syndrome, and necrotizing skin reactions. Systemic NSAID toxicity, though rare with topical use, can manifest as gastrointestinal ulceration, renal impairment, or hepatic enzyme elevation, especially in patients with pre‑existing organ dysfunction or when used with interacting medicines.

Individuals with known hypersensitivity to diclofenac, other NSAIDs, or any component of the formulation should avoid this product. It is also contraindicated on infected, broken, or ulcerated skin, and in patients with severe renal, hepatic, or cardiovascular disease unless specifically advised by a physician.